Mary Ellen Pavone1, Serdar E Bulun. 1. Division of Reproductive Biology, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. mpavone@nmff.org
Abstract
OBJECTIVE: To review the use of aromatase inhibitors (AIs) for the treatment of endometriosis. DESIGN: Literature review. CONCLUSION(S): Most studies show that in reproductive-age women, the combination of AI with conventional therapy alleviates endometriosis-related pain. In postmenopausal women, using an AI alone has been shown to be an effective treatment, although more studies are needed in this subgroup. Side effects of using AIs appear to be tolerable in most women, although special consideration should be given to monitoring bone mineral density. More studies need to be done examining pregnancy rates and outcomes after AI treatment for endometriosis. In addition, larger randomized clinical trials using AIs need to be done. In summary, AIs may be effective in treating endometriosis-related chronic pelvic pain in both reproductive-age and postmenopausal women.
OBJECTIVE: To review the use of aromatase inhibitors (AIs) for the treatment of endometriosis. DESIGN: Literature review. CONCLUSION(S): Most studies show that in reproductive-age women, the combination of AI with conventional therapy alleviates endometriosis-related pain. In postmenopausal women, using an AI alone has been shown to be an effective treatment, although more studies are needed in this subgroup. Side effects of using AIs appear to be tolerable in most women, although special consideration should be given to monitoring bone mineral density. More studies need to be done examining pregnancy rates and outcomes after AI treatment for endometriosis. In addition, larger randomized clinical trials using AIs need to be done. In summary, AIs may be effective in treating endometriosis-related chronic pelvic pain in both reproductive-age and postmenopausal women.
Authors: Richard S Legro; Allen R Kunselman; Robert G Brzyski; Peter R Casson; Michael P Diamond; William D Schlaff; Gregory M Christman; Christos Coutifaris; Hugh S Taylor; Esther Eisenberg; Nanette Santoro; Heping Zhang Journal: Contemp Clin Trials Date: 2012-01-13 Impact factor: 2.226
Authors: Antonio Llombart; Antonio Frassoldati; Outi Paija; Harm Peter Sleeboom; Guy Jerusalem; Jeroen Mebis; Ines Deleu; Joel Miller; Nora Schenk; Patrick Neven Journal: Clin Breast Cancer Date: 2011-10-19 Impact factor: 3.225
Authors: Adam M Brufsky; W Graydon Harker; J Thaddeus Beck; Linda Bosserman; Charles Vogel; Christopher Seidler; Lixian Jin; Ghulam Warsi; Eliza Argonza-Aviles; John Hohneker; Solveig G Ericson; Edith A Perez Journal: Cancer Date: 2011-10-10 Impact factor: 6.860
Authors: Fadi Abushahin; Kara N Goldman; Elizabeth Barbieri; Magdy Milad; Alfred Rademaker; Serdar E Bulun Journal: Fertil Steril Date: 2011-08-24 Impact factor: 7.329
Authors: Hong Zhao; Elizabeth K Pearson; David C Brooks; John S Coon; Dong Chen; Masashi Demura; Ming Zhang; Charles V Clevenger; Xia Xu; Timothy D Veenstra; Robert T Chatterton; Francesco J DeMayo; Serdar E Bulun Journal: Endocrinology Date: 2012-04-16 Impact factor: 4.736
Authors: Jennifer A Ligibel; A James O'Malley; Maxine Fisher; Gregory W Daniel; Eric P Winer; Nancy L Keating Journal: Breast Cancer Res Treat Date: 2012-07-12 Impact factor: 4.872